Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBLB | Q13191 | 17/20 | 0.74 |
| ▸ | CCKAR | P32238 | 5/20 | 0.59 |
| ▸ | CCKBR | P32239 | 3/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6064825 | 0.90 | CBLB (0.60) | CBLBCCKARCCKBR | |
| SCHEMBL6064671 | 0.90 | CBLB (0.60) | CBLBCCKARCCKBR | |
| SCHEMBL3822275 | 0.86 | CBLB (0.65) | CBLBCCKARCCKBR | |
| SCHEMBL3824525 | 0.84 | CBLB (0.72) | CBLBCCKARCCKBR | |
| SCHEMBL3824114 | 0.84 | CBLB (0.72) | CBLBCCKARCCKBR | |
| SCHEMBL3827059 | 0.83 | CBLB (0.77) | CBLBCCKARCCKBR | |
| SCHEMBL3829298 | 0.81 | CBLB (0.64) | CBLBCCKARCCKBR | |
| SCHEMBL642815 | 0.80 | CCKBR (0.67) | CCKARCCKBR | |
| SCHEMBL643303 | 0.80 | CBLB (0.68) | CBLBCCKARCCKBR | |
| SCHEMBL3823353 | 0.79 | CBLB (0.55) | CBLBCCKARCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070185096-A1 | Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein | NOVARTIS PHARMACEUTICALS CORPORATION (US) | 2007-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185096-A1 | Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein | GABRP, TSPO, GABRA1 | CBLB 3827/4885CCKAR 2354/4885CCKBR 2243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.